Suppr超能文献

通过部分玻璃体切割术建立前房与玻璃体腔之间的沟通来评估人工晶状体眼恶性青光眼手术治疗的有效性。

Evaluation of the Effectiveness of Surgical Treatment of Malignant Glaucoma in Pseudophakic Eyes through Partial PPV with Establishment of Communication between the Anterior Chamber and the Vitreous Cavity.

作者信息

Rękas Marek, Krix-Jachym Karolina, Żarnowski Tomasz

机构信息

Ophthalmology Department, Military Institute of Medicine, Szaserów Street 128, 04-141 Warsaw, Poland.

Department of Diagnostics and Microsurgery of Glaucoma, Medical University of Lublin, Chmielna Street 1, 20-079 Lublin, Poland.

出版信息

J Ophthalmol. 2015;2015:873124. doi: 10.1155/2015/873124. Epub 2015 Aug 12.

Abstract

Purpose. Determination of partial posterior vitrectomy (PPV) in the proposed modification for treatment of malignant glaucoma. Methods. The prospective, consecutive, single-center case series study involved patients in whom symptoms of malignant glaucoma occurred after combined cataract and glaucoma surgery or after glaucoma surgery in pseudophakic eye. When medical and laser treatment were not successful, partial PPV with establishment of communication between the anterior chamber and the vitreous cavity was performed. Efficacy measures were intraocular pressure (IOP) reduction, corrected distance visual acuity (CDVA), AND the number of antiglaucoma medications. Surgical success and occurring complications were also evaluated. Results. The study enrolled 20 eyes of 17 patients. Average IOP was reduced from 30.4 ± 14.2 (SD) mmHg to 14.6 ± 3.2 (SD) mmHg one year after surgery (P < 0.00001). A statistically significant reduction of the number of antiglaucoma medications was obtained from 3.3 ± 1.1 (SD) preoperatively to 1.2 ± 1.1 (SD) at the end of follow-up. Statistically significant improvement of CDVA was observed 3, 6, and 12 months after surgery. Conclusions. Partial PPV with establishment of communication between the anterior chamber and the vitreous cavity enables effective IOP control over a 12-month observation; however, in most cases, it is necessary to use antiglaucoma medications for IOP control.

摘要

目的。确定改良的部分玻璃体后脱离术(PPV)在恶性青光眼治疗中的应用。方法。这项前瞻性、连续性、单中心病例系列研究纳入了在白内障合并青光眼手术或人工晶状体眼青光眼手术后出现恶性青光眼症状的患者。当药物和激光治疗无效时,进行部分PPV并建立前房与玻璃体腔之间的通道。疗效指标包括眼压(IOP)降低、矫正远视力(CDVA)以及抗青光眼药物的使用数量。同时评估手术成功率和出现的并发症。结果。该研究纳入了17例患者的20只眼。术后1年平均眼压从30.4±14.2(标准差)mmHg降至14.6±3.2(标准差)mmHg(P<0.00001)。抗青光眼药物使用数量从术前的3.3±1.1(标准差)显著减少至随访结束时的1.2±1.1(标准差)。术后3、6和12个月时CDVA有统计学意义的改善。结论。建立前房与玻璃体腔之间通道的部分PPV在12个月的观察期内能够有效控制眼压;然而,在大多数情况下,仍需要使用抗青光眼药物来控制眼压。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0a7/4549569/301699e2f4dc/JOPH2015-873124.001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验